Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GENZYME CORP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioFlorida Conference
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2028-08-08

VANDETANIB

US Patent Number : 8067427

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22405

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-08

Sanofi Company Banner

02

arrow
BioFlorida Conference
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2028-08-08

VANDETANIB

US Patent Number : 8067427

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22405

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-08

Sanofi Company Banner